HUMA - Humacyte Corp Net earnings per share (EPS TTM)

Official company branding of Humacyte Inc (HUMA)

Net income per share over the last four quarters demonstrates a trend where the parameter value equals -0.49. Humacyte, Inc. (HUMA) delegates implant manufacturing and logistics to external partners to advance its technologies. The business relies on the exclusive right to determine pricing for bio-vessels due to inelastic demand, granting the company significant pricing power. A narrow specialization in the tissue platform is offset by innovation, although developments remain at the pre-commercial stage.

HUMA Humacyte, Inc. Net earnings per one share for the last twelve months (07/04/2022 - 11/10/2026)

Analytical breakdowns for Humacyte Inc (HUMA)

- share price and expert price forecast:
Stock Quotes Humacyte, Inc.|HUMA - Analyst Forecast Prices
- market capitalization statistics:
Market Capitalization Humacyte, Inc.|HUMA - Company Buyout Price
- business book valuation details:
Net Assets per Single Share Humacyte|HUMA - Total Stockholders' Equity|Market Value to Book Value Ratio humacyte.com|HUMA - Total Business Assets
- issuer credit burden and liquidity indicators:
Total Debt to Capital Humacyte, Inc.|HUMA - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Ratio Humacyte Corp|HUMA - Company Aggregate Debts|Debt to Book Capitalization Ratio Humacyte, Inc.|HUMA - Company Long-Term Liabilities|Company Short-Term Debts Humacyte|Quick Ratio humacyte.com
- earnings and multiples data:
HUMA - Net Income|Future Profit Humacyte, Inc.|HUMA - Market Cap to Earnings|Projected Price to Earnings Humacyte|HUMA - Company Value to Earnings Growth Ratio|EV/EBITDA Multiple Humacyte, Inc.|HUMA - Profit before interest, taxes and amortization|Net earnings per share for the last 12 months Humacyte|HUMA - Earnings per share for the trailing year|Quarterly EPS earnings growth humacyte.com|HUMA - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year Humacyte, Inc.
Analysis of all company metrics:HUMA - Humacyte, Inc.
Manufactured products of Humacyte Inc.

For Humacyte, Inc. (HUMA), the trailing 12-month net income per share chart visualizes the business's equity efficiency by dividing the aggregate financial result by the total number of shares to determine the actual return per security. This indicator's trend captures how successfully bioengineered developments are being transformed into capital, which is critical while awaiting regulatory approvals and scaling tissue production.

Competitor analysis

NTRA: Net earnings per share for the last 12 months|seraprognostics.com - Earnings per share for the last four quarters